Nonlinear pharmacokinetics in critically ill patients.

Pharmacokinetics of intravenous caffeine in critically ill patients.

Population pharmacokinetics of omeprazole in critically ill pediatric patients.

Pharmacokinetics of midazolam in critically ill neonates.

Single-dose linezolid pharmacokinetics in critically ill patients with impaired renal function especially chronic hemodialysis patients.

Hyponatremia in critically ill patients.

Sedation in critically ill patients.

Pharmacokinetics of lorazepam in critically ill neonates with seizures.

Population pharmacokinetics of phenytoin in critically ill children.

Population Pharmacokinetics of Doripenem in Critically Ill Patients with Sepsis in a Malaysian Intensive Care Unit.

Effect of Obesity on the Population Pharmacokinetics of Meropenem in Critically Ill Patients.

Ciprofloxacin pharmacokinetics in critically ill patients receiving concomitant continuous venovenous hemodialysis.

Gentamicin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration (CVVHDF).

Pharmacokinetics of fluconazole in critically ill patients with acute kidney injury receiving sustained low-efficiency diafiltration.

Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill Patients.

Pharmacokinetics Alterations of Midazolam Infusion versus Bolus Administration in Mechanically Ventilated Critically Ill Patients.

Population Pharmacokinetics in China: The Dynamics of Intravenous Voriconazole in Critically Ill Patients with Pulmonary Disease.

Intubation of critically ill patients.

Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill Patients.

Pharmacokinetics and pharmacodynamics of imipenem and meropenem in critically ill patients treated with continuous venovenous hemodialysis.

Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration.

Pharmacokinetics of vancomycin in critically ill patients undergoing continuous venovenous haemodialysis.

Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients.

Pharmacokinetics of sufentanil during long-term infusion in critically ill pediatric patients.

Pharmacokinetics and the optimal regimen for levofloxacin in critically ill patients receiving continuous hemodiafiltration.

Suggest Documents

Pharmacokinetics of intravenous caffeine in critically ill patients.

Population pharmacokinetics of omeprazole in critically ill pediatric patients.

Pharmacokinetics of midazolam in critically ill neonates.

Single-dose linezolid pharmacokinetics in critically ill patients with impaired renal function especially chronic hemodialysis patients.

Hyponatremia in critically ill patients.

Sedation in critically ill patients.

Pharmacokinetics of lorazepam in critically ill neonates with seizures.

Population pharmacokinetics of phenytoin in critically ill children.

Population Pharmacokinetics of Doripenem in Critically Ill Patients with Sepsis in a Malaysian Intensive Care Unit.

Effect of Obesity on the Population Pharmacokinetics of Meropenem in Critically Ill Patients.

Ciprofloxacin pharmacokinetics in critically ill patients receiving concomitant continuous venovenous hemodialysis.

Gentamicin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration (CVVHDF).

Pharmacokinetics of fluconazole in critically ill patients with acute kidney injury receiving sustained low-efficiency diafiltration.

Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill Patients.

Pharmacokinetics Alterations of Midazolam Infusion versus Bolus Administration in Mechanically Ventilated Critically Ill Patients.

Population Pharmacokinetics in China: The Dynamics of Intravenous Voriconazole in Critically Ill Patients with Pulmonary Disease.

Intubation of critically ill patients.

Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill Patients.

Pharmacokinetics and pharmacodynamics of imipenem and meropenem in critically ill patients treated with continuous venovenous hemodialysis.

Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration.

Pharmacokinetics of vancomycin in critically ill patients undergoing continuous venovenous haemodialysis.

Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients.

Pharmacokinetics of sufentanil during long-term infusion in critically ill pediatric patients.

Pharmacokinetics and the optimal regimen for levofloxacin in critically ill patients receiving continuous hemodiafiltration.

Nonlinear pharmacokinetics in critically ill patients.

Recommend Documents

Follow Us